PRESS RELEASE published on 09/04/2024 at 12:30, 1 year 9 months ago Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome Immunic announces enrollment of the first patient in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium for Post COVID Syndrome. Study aims to suppress EBV reactivation and fatigue symptoms Clinical Trial Immunic Vidofludimus Calcium Phase 2 Post COVID Syndrome
BRIEF published on 08/28/2024 at 12:35, 1 year 10 months ago Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September Multiple Sclerosis Immunic Vidofludimus Calcium R&D Day Scientific Conferences
BRIEF published on 08/28/2024 at 12:35, 1 year 10 months ago Immunic organise une journée de recherche et développement sur la sclérose en plaques et participe à des conférences scientifiques et d'investisseurs en septembre Sclérose En Plaques Conférences Scientifiques Journée R&D Immunique Vidofludimus Calcique
PRESS RELEASE published on 08/28/2024 at 12:30, 1 year 10 months ago Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September Immunic to host Multiple Sclerosis R&D Day & participate in conferences. Immunic, Inc. develops oral therapies for autoimmune diseases Investor Conferences Multiple Sclerosis Immunic R&D Day Scientific Conferences
BRIEF published on 08/08/2024 at 12:35, 1 year 10 months ago Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update Financial Results Biotechnology Clinical Trials Multiple Sclerosis Immunic
BRIEF published on 08/08/2024 at 12:35, 1 year 10 months ago Immunic, Inc. publie ses résultats financiers du deuxième trimestre 2024 et fait le point sur son entreprise Résultats Financiers Biotechnologie Essais Cliniques Sclérose En Plaques Immunitaire
PRESS RELEASE published on 08/08/2024 at 12:30, 1 year 10 months ago Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update Immunic, Inc. reports Q2 2024 financial results and corporate update, appoints new COO & strengthens BOD. Webcast on August 8. Ongoing trials remain on track Financial Results Clinical Trials Corporate Update Immunic Inc. COO Appointment
BRIEF published on 08/01/2024 at 12:35, 1 year 10 months ago Immunic, Inc. to Announce Financial Results for Q2 2024 and Provide Corporate Update Biotechnology Clinical Trials Webcast Immunic, Inc. Q2 Financial Results
BRIEF published on 08/01/2024 at 12:35, 1 year 10 months ago Immunic, Inc. annoncera ses résultats financiers pour le deuxième trimestre 2024 et fournira une mise à jour de l'entreprise Biotechnologie Immunic, Inc. Webdiffusion Essais Cliniques Résultats Financiers Du Deuxième Trimestre
PRESS RELEASE published on 08/01/2024 at 12:30, 1 year 10 months ago Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update Immunic, Inc. to announce Q2 2024 financial results and corporate update on August 8, 2024, including webcast participation details. Company developing therapies for inflammatory diseases Financial Results Webcast Immunic Inc. Q2 2024 Inflammatory Diseases
Published on 06/29/2026 at 12:00, 39 minutes ago Completes Initial Development of Remote Satellite Camera System for Military & Environmental Applications
Published on 06/29/2026 at 12:00, 39 minutes ago Pivotree Inc. Announces Results from Its Annual and Special Meeting of Shareholders
Published on 06/29/2026 at 09:01, 3 hours 38 minutes ago HM Exploration Discovers New Blind Massive Sulphide Lens at Lewis Pilley's Project
Published on 06/27/2026 at 16:50, 1 day 19 hours ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 2 days 10 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/29/2026 at 12:25, 14 minutes ago Envision Energy and Elements Green Partner on 1,600MWh Stadorf BESS, Scaling Future Energy Systems in Germany
Published on 06/29/2026 at 12:21, 18 minutes ago Gerresheimer Publishes 2025 Annual and Consolidated Financial Statements: Stable Revenue in a Challenging Financial Year
Published on 06/29/2026 at 12:05, 34 minutes ago Trust3 AI Brings Its Agent Control Plane to Microsoft Copilot Studio
Published on 06/29/2026 at 11:40, 59 minutes ago Five ZPMC Production Sites Earn National Smart Manufacturing Certification
Published on 06/29/2026 at 11:03, 1 hour 35 minutes ago PNE successful in onshore wind energy tender on May 1, 2026
Published on 06/29/2026 at 10:56, 1 hour 43 minutes ago GUILLEMOT CORPORATION S.A. | Déclaration hebdomadaire des transactions sur actions propres du 22 au 26 juin 2026
Published on 06/29/2026 at 10:56, 1 hour 43 minutes ago GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026